Johnson & Johnson (NYSE: JNJ) today announced the submission of a supplemental Biologics License Application (sBLA) to the U.S. Food and Drug Administration (FDA), seeking approval of IMAAVY® ...
FY 2025 Total Revenue of $510 Million, Representing 20% Year-Over-Year GrowthFY 2025 ASCENIV Revenue Grew to $363 Million, Representing 51% ...
On January 28, SlateStone Wealth chief market strategist Kenny Polcari discussed small-cap stock performance on FOX Business ...
Sanofi’s estimated fair value has been adjusted slightly, with the price target moving from €99.14 to €98.49. Analysts link this small change to a more balanced view of the stock, weighing execution ...
60 Degrees Pharmaceuticals Inc. (NASDAQ:SXTP) is one of the best up and coming penny stocks to buy. On February 2, 60 Degrees Pharmaceuticals announced a partnership with GoodRx to enhance the ...
Alkermes plc announced today that management will participate in a fireside chat at the TD Cowen 46th Annual Health Care Conference on Monday, March 2, 2026 at 9:10 a.m. ET (2:10 p.m. GMT). The live ...
Poor sleep is linked to significantly higher rates of self-injury, suicidal thoughts and aggression among autistic children and adults, according to a new peer-reviewed study by researchers at the ...
Fulcrum Therapeutics, Inc. ( FULC) Q4 2025 Earnings Call February 24, 2026 8:00 AM EST Good morning, and welcome to the Fulcrum Therapeutics conference call to discuss 12-week data from the ...
Opportunities in the C5 inhibitors market include developing next-gen biosimilars and biosuperiors to improve administration frequency and expand treatment indications for diseases like aHUS, SCD, MG, ...
Anaemia is the reduction in the number of circulating erythrocytes in the blood, or a reduction in the quantity of haemoglobin. Allogeneic stem cell transplantation (alloHSCT) is approved for the ...